COAG
Laboratory920 LOINC codes in this class
75511-6dRVVT W excess phospholipid percent correctionL3197-1Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Coagulation assayL50747-5Platelet factor 4 Ag [Presence] in Platelet poor plasma by ImmunoassayL3228-4Coagulation factor XI Ag [Units/volume] in Platelet poor plasma by ImmunoassayL40088-7Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --baselineL50947-1Platelet aggregation interpretation in Platelet rich plasma Qualitative by Collagen induced.190 ug/mLL56006-0Platelet aggregation in Blood by ADP induced 10 umol/LL33612-3Phosphatidylinositol Ab [Units/volume] in SerumL66760-0Coagulation index in Blood by ThromboelastographyL5893-3Protein S [Units/volume] in Platelet poor plasma by Chromogenic methodL3186-4Coagulation factor IX activity [Units/volume] in Platelet poor plasma by Coagulation assayL14243-0Phosphatidylcholine IgG Ab [Presence] in SerumL17449-0Phosphatidylethanolamine IgG Ab [Presence] in SerumL56027-6Platelet aggregation in Blood by ristocetin induced 1.0 mg/mLL5991-5Plasminogen Ag [Units/volume] in Platelet poor plasma by ImmunoassayL33529-9Platelet aggregation in Control Platelet rich plasma by ADP induced Low doseL51868-8Thrombin time.factor substitution immediately after addition of XXX in Platelet poor plasma by Coagulation assayL57760-1Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Coagulation assayL49845-1aPTT.factor substitution with normal plasma 1H post incubation separate tubes in Platelet poor plasma by Coagulation assayL50945-5Platelet aggregation interpretation in Platelet rich plasma Qualitative by Adenosine diphosphate induced.2 umol/LL52784-6Maximum lysis [Length fraction] in Blood by ThromboelastographyL58481-3Protein C Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by ImmunoassayL49844-4aPTT.factor substitution 1H post incubation with 1:4 normal plasma in Platelet poor plasma by Coagulation assayL5980-8Plasminogen activator inhibitor Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL14244-8Phosphatidylcholine IgM Ab [Presence] in SerumL80627-3Coagulation factor X activated inhibitor [Mass/volume] in Platelet poor plasmaL33522-4Platelet aggregation in Platelet rich plasma by ristocetin induced High doseL50946-3Platelet aggregation interpretation in Platelet rich plasma Qualitative by Adenosine diphosphate induced.4 umol/LL34375-6Streptokinase Ab [Titer] in SerumL53567-4Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 0.1 ug/mLL47300-9Phosphatidate IgM Ab [Units/volume] in Serum by ImmunoassayL17456-5Phosphatidylinositol IgM Ab [Presence] in SerumL50391-2Coag.Surface induced circulating inhibitor [Presence] in Platelet poor plasma by Coagulation assayL3288-8Prothrombin Ag [Units/volume] in Platelet poor plasma by ImmunoassayL56013-6Platelet aggregation in Blood by arachidonate induced ATP secretion 500 umol/LL33521-6Platelet aggregation in Platelet rich plasma by collagen induced Low doseL74809-5von Willebrand factor (vWf).activity actual/normal in Control Platelet poor plasma by ImmunoassayL5995-6Platelet aggregation in Platelet rich plasma by collagen inducedL10521-3Coagulation factor VIII Ag [Presence] in Tissue by Immune stainL5996-4Platelet aggregation in Platelet rich plasma by EPINEPHrine inducedL40100-0aPTT in Platelet poor plasma by Coagulation assay --baselineL3227-6Coagulation factor XI activity [Units/volume] in Platelet poor plasma by Chromogenic methodL50637-8Coagulation factor XIII inhibitor [Presence] in Platelet poor plasma by Chromogenic methodL58493-8Coagulation factor VIII Ab [Presence] in Platelet poor plasma by ImmunoassayL33533-1Platelet aggregation in Control Platelet rich plasma by ristocetin induced Low doseL17454-0Phosphatidylinositol IgA Ab [Presence] in SerumL13054-2Fibrin+Fibrinogen fragments [Units/volume] in UrineL56007-8Platelet aggregation in Blood by arachidonate induced 500 ug/mLL60242-5Coagulation ecarin induced in Platelet poor plasma by Coagulation assayL3238-3Coagulation factor XIII Ag [Units/volume] in Platelet poor plasma by ImmunoassayL33891-3aPTT.factor substitution 2H post incubation with normal plasma in Platelet poor plasma from Control by Coagulation assayL3239-1Coagulation factor XIII Ag actual/normal in Platelet poor plasma by ImmunoassayL56008-6Platelet aggregation in Blood by collagen induced 1 ug/mLL33531-5Platelet aggregation in Control Platelet rich plasma by arachidonate inducedL3214-4Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by ImmunoelectrophoresisL33588-5Phosphatidylethanolamine Ab [Units/volume] in Serum by ImmunoassayL53568-2Platelet aggregation in Platelet rich plasma by arachidonate induced 500 ug/mLL58482-1Protein S Ag/Coagulation factor IX Ag [Mass Ratio] in Platelet poor plasma by ImmunoassayL17450-8Phosphatidylethanolamine IgM Ab [Presence] in SerumL27813-5Prothrombin Ag actual/normal in Platelet poor plasma by ImmunoassayL52767-1Activated partial thromboplastin time (aPTT) in Platelet poor plasma by Coagulation assay -- after addition of protein C activator/Activated partial thromboplastin time (aPTT)L30902-1Fibrinogen [Mass/volume] in Platelet poor plasma by Heat denaturationL13594-7Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasmaL13592-1Platelet aggregation in Platelet rich plasma by XXX inducedL3194-8Coagulation factor V Ag [Units/volume] in Platelet poor plasma by ImmunoassayL10523-9Fibrinogen Ag [Presence] in Tissue by Immune stainL3217-7Coagulation factor X activity [Units/volume] in Platelet poor plasma by Coagulation assayL52750-7Activated protein C resistance [Presence] in Platelet poor plasma by Coagulation assayL33523-2Platelet aggregation in Platelet rich plasma by ristocetin induced Low doseL14242-2Phosphatidylcholine IgA Ab [Presence] in SerumL3234-2Coagulation factor XII Ag [Units/volume] in Platelet poor plasma by ImmunoassayL33532-3Platelet aggregation in Control Platelet rich plasma by ristocetin induced High doseL53222-6Coagulation factor XI activity [Units/volume] in Platelet poor plasma by Coagulation assayL74808-7von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay --immediately after 1:1 addition of normal plasmaL56010-2Platelet aggregation in Blood by ristocetin induced 250 ug/mLL68916-6dRVVT W excess phospholipid actual/normal (normalized LA confirm)L5973-3Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasisL5900-6Prothrombin Fragment 1.2 [Units/volume] in Serum or PlasmaL3178-1Bleeding time by Duke methodL56538-2Beta 2 glycoprotein 1 Ab [Units/volume] in Serum by ImmunoassayL33892-1aPTT.factor substitution immediately after 1:4 addition of normal plasma in Platelet poor plasma from Control by Coagulation assayL3231-8Coagulation factor XII activity [Units/volume] in Platelet poor plasma by Coagulation assayL48591-2Activated protein C resistance [Interpretation] in Platelet poor plasmaL24379-0Platelet aggregation interpretation in Platelet rich plasma Qualitative induced by CollagenL42499-4Fibrin D-dimer [Presence] in Cerebral spinal fluidL56005-2Platelet aggregation in Blood by ADP induced 5 umol/LL5993-1Platelet aggregation in Platelet rich plasma by arachidonate inducedL13591-3Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assayL3268-0Heparin cofactor II Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL34590-0von Willebrand factor (vWf) cleaving protease inhibitor [Presence] in Platelet poor plasmaL17448-2Phosphatidylethanolamine IgA Ab [Presence] in SerumL3201-1Coagulation factor VII Ag [Units/volume] in Platelet poor plasma by ImmunoassayL3278-9Kininogen HMW actual/normal in Platelet poor plasma by ImmunoassayL3252-4Fibrin+Fibrinogen fragments [Units/volume] in Serum by Latex agglutinationL3250-8Fibrin monomer [Units/volume] in Platelet poor plasma by Latex agglutinationL28659-1Prekallikrein (Fletcher Factor) actual/normal in Platelet poor plasma by Chromogenic methodL3230-0Coagulation factor XII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL17459-9Phospholipid IgA Ab [Units/volume] in Serum by ImmunoassayL31158-9Fibrinogen Ag/Fibrinogen [Mass Ratio] in Platelet poor plasmaL3221-9Coagulation factor X Ag actual/normal in Platelet poor plasma by ImmunoassayL10522-1Coagulation factor XIII Ag [Presence] in Tissue by Immune stainL6003-8Platelet factor 4 Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3199-7Coagulation factor VII activity [Units/volume] in Platelet poor plasma by Chromogenic methodL47030-2Phosphatidate IgA Ab [Units/volume] in Serum by ImmunoassayL5986-5Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic methodL5950-1aPTT.factor substitution 20M post incubation with normal plasma in Platelet poor plasma by Coagulation assayL3190-6Coagulation factor IX Ag actual/normal in Platelet poor plasma by ImmunoassayL30009-5Fibrin+Fibrinogen fragments [Mass/volume] in SerumL80659-6Activated clotting time (ACT) of Blood induced by KaolinL34589-2von Willebrand factor (vWf) cleaving protease [Presence] in Platelet poor plasmaL14010-3Phosphatidylcholine IgA Ab [Units/volume] in Serum by ImmunoassayL40457-4Prothrombin Ab [Units/volume] in Serum or PlasmaL52785-3Maximum lysis [Length fraction] in Blood by Thromboelastography.rotational.extrinsic coagulation system activated.fibrinolysis suppressedL40454-1Clot Lysis [Presence] in Platelet poor plasma by Coagulation assayL5942-8Reptilase time in Platelet poor plasma from Control by Coagulation assayL4671-4Protein C [Mass/volume] in PlasmaL3216-9Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL3177-3Antithrombin Ag [Moles/volume] in Platelet poor plasma by ImmunoassayL24385-7Cardiolipin IgG Ab [Presence] in Serum by ImmunoassayL4668-0Plasminogen Ag [Mass/volume] in Platelet poor plasmaL5987-3Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic methodL33519-0Platelet aggregation in Platelet rich plasma by ADP induced Low doseL3220-1Coagulation factor X Ag [Units/volume] in Platelet poor plasma by ImmunoassayL14008-7Phosphatidylcholine IgG Ab [Units/volume] in Serum by ImmunoassayL33673-5Thrombin time.factor substitution immediately after addition of protamine sulfate in Platelet poor plasma by Coagulation assayL52772-1Clot formation [Time] in Blood by Thromboelastography.rotational.intrinsic coagulation system activated.heparin insensitiveL5965-9Plasmin inhibitor [Units/volume] in Platelet poor plasma by Chromogenic methodL24376-6von Willebrand factor (vWf) multimers in Platelet poor plasma by ImmunoassayL30470-9Cardiolipin IgA Ab [Presence] in SerumL71427-9Fibrin D-dimer [Mass/volume] in Blood by Rapid immunoassayL48664-7Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation.derivedL14009-5Phosphatidylcholine IgM Ab [Units/volume] in Serum by ImmunoassayL3213-6Coagulation factor VIII Ag [Units/volume] in Platelet poor plasma by ImmunoassayL3244-1Clot Lysis [Time] in Platelet poor plasma by Coagulation assayL3189-8Coagulation factor IX Ag [Units/volume] in Platelet poor plasma by ImmunoassayL6005-3Prekallikrein (Fletcher Factor) [Units/volume] in Platelet poor plasmaL5974-1Plasminogen activator inhibitor 1 [Units/volume] in Platelet poor plasma by Chromogenic methodL5990-7Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --20 minutes post venistasisL60278-9Fibrinogen Ag [Presence] in Tissue by ImmunofluorescenceL52770-5Clot formation [Time] in Blood by Thromboelastography.rotational.extrinsic coagulation system activatedL13053-4Kaolin activated time [Units/volume] in Platelet poor plasma by Coagulation assayL63561-5aPTT actual/normal in Platelet poor plasma by Coagulation assayL52754-9Kininogen HMW activity actual/normal in Platelet poor plasma by Coagulation assayL15362-7aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assayL33884-8Prothrombin time (PT) factor substitution 1H post incubation with normal plasma in Platelet poor plasma from Control by Coagulation assayL5992-3Platelet aggregation in Platelet rich plasma by ADP inducedL5966-7Plasmin inhibitor Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3211-0Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation.2 stageL20485-9Cardiolipin IgM Ab [Titer] in SerumL6010-3Protein C inhibitor [Mass/volume] in Platelet poor plasma by ImmunoassayL13072-4Phosphatidate IgA Ab [Units/volume] in SerumL13071-6Phosphatidate IgM Ab [Units/volume] in SerumL13070-8Phosphatidate IgG Ab [Units/volume] in SerumL16630-6aPTT saline 1:1 in Blood from Control by Coagulation assayL3237-5Coagulation factor XIII activity [Units/volume] in Platelet poor plasma by Coagulation assayL46224-2Thrombin time after addition of heparinase in Platelet poor plasma by Coagulation assayL24377-4Platelet aggregation interpretation in Platelet rich plasma Qualitative Induced by Adenosine diphosphateL13075-7Phosphatidylcholine IgA Ab [Units/volume] in SerumL13074-0Phosphatidylcholine IgM Ab [Units/volume] in SerumL13073-2Phosphatidylcholine IgG Ab [Units/volume] in SerumL5976-6Plasminogen activator inhibitor 1 [Mass/volume] in Platelet poor plasma by Chromogenic methodL4672-2Protein C Ag [Mass/volume] in Platelet poor plasmaL33310-4Phosphatidylserine Ab [Presence] in SerumL75509-0aPTT.lupus sensitive with 1:1 PNP actual/Normal (normalized LA mix)L75508-2aPTT.lupus sensitive W excess phospholipid actual/Normal (normalized LA confirm)L75884-7aPTT.lupus sensitive/aPTT.lupus sensitive W excess phospholipid (screen to confirm ratio)L15159-7Coagulation factor extrinsic pathway [Interpretation] in Platelet poor plasma NarrativeL33308-8Phosphatidylethanolamine Ab [Presence] in SerumL27824-2Prothrombin Fragment 1.2 Ag [Moles/volume] in Serum or Plasma by ImmunoassayL74220-5Dabigatran [Mass/volume] in Platelet poor plasma by Coagulation assayL54219-1Thrombin time.factor substitution immediately after 1:4 addition of normal plasma in Platelet poor plasma by Coagulation assayL50950-5Phosphoethanolamine IgA Ab [Presence] in Serum or PlasmaL40089-5Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --30 minutes post XXX challengeL33880-6Prothrombin time (PT) factor substitution 2H post incubation with normal plasma in Platelet poor plasma from Control by Coagulation assayL5971-7Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL49843-6aPTT.factor substitution 2H post incubation with 1:4 normal plasma in Platelet poor plasma by Coagulation assayL33887-1Prothrombin time (PT) factor substitution 2H post incubation with normal plasma in Platelet poor plasma by Coagulation assayL18345-9Protein S Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by Coagulation assayL5956-8Prothrombin time (PT) factor substitution immediately after addition of normal plasma in Platelet poor plasma from Control by Coagulation assayL43869-7Antithrombin Ag [Presence] in Platelet poor plasma by ImmunoassayL50390-4Coagulation factor II circulating inhibitor [Presence] in Platelet poor plasmaL13083-1Phosphatidylinositol IgM Ab [Units/volume] in SerumL3224-3Coagulation factor XI inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL46717-5Thrombin time.factor substitution immediately after addition of bovine thrombin in Platelet poor plasma by Coagulation assayL9327-8Phosphatidylserine IgM Ab [Presence] in Serum by ImmunoassayL9326-0Phosphatidylserine IgG Ab [Presence] in Serum by ImmunoassayL75506-6aPTT.lupus sensitive W excess phospholipid (LA confirm)L52786-1Maximum lysis [Length fraction] in Blood by Thromboelastography.rotational.extrinsic coagulation system activatedL13079-9Phosphatidylglycerol IgG Ab [Units/volume] in SerumL13081-5Phosphatidylglycerol IgA Ab [Units/volume] in SerumL13080-7Phosphatidylglycerol IgM Ab [Units/volume] in SerumL27438-1Protein C Ag/Coagulation factor VII Ag [Mass Ratio] in Platelet poor plasma by ImmunoassayL13084-9Phosphatidylinositol IgA Ab [Units/volume] in SerumL13082-3Phosphatidylinositol IgG Ab [Units/volume] in SerumL49870-9Coagulation factor VII Ag actual/normal in Platelet poor plasma by ImmunoassayL33987-9Heparin cofactor II actual/normal in Platelet poor plasma by Chromogenic methodL3196-3Coagulation factor VII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL13078-1Phosphatidylethanolamine IgA Ab [Units/volume] in SerumL13076-5Phosphatidylethanolamine IgG Ab [Units/volume] in SerumL13077-3Phosphatidylethanolamine IgM Ab [Units/volume] in SerumL33357-5Prothrombin time (PT) factor substitution 1 hours post incubation in Platelet poor plasma by Coagulation assayL48590-4aPTT after addition of APC in Platelet poor plasma by Coagulation assayL16631-4aPTT saline 1:1 in Blood by Coagulation assayL3206-0Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Coagulation assayL40456-6Beta 2 glycoprotein 1 Ab [Units/volume] in SerumL15160-5Coagulation factor Intrinsic Factor [Interpretation] in Platelet poor plasma NarrativeL33528-1Platelet aggregation in Control Platelet rich plasma by ADP induced High doseL50377-1von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by ImmunoassayL69918-1Thrombin time.high dose in Platelet poor plasma by Coagulation assayL11067-6Bleeding timeL52771-3Clot formation [Time] in Blood by Thromboelastography.rotational.intrinsic coagulation system activatedL33526-5Reptilase time.factor substitution immediately after addition of normal plasma in Platelet poor plasma by Coagulation assayL15361-9aPTT.factor substitution immediately after 1:4 addition of normal plasma in Platelet poor plasma by Coagulation assayL14182-0Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL56014-4Platelet aggregation in Blood by collagen induced ATP secretion 5 ug/mLL3269-8Heparin neutralization [Presence] in Platelet poor plasmaL43361-5Cardiolipin IgA Ab [Mass/volume] in SerumL50754-1aPTT in Platelet poor plasma from Pooled by Coagulation assayL27810-1Plasmin inhibitor actual/normal in Platelet poor plasma by Chromogenic methodL34572-8aPTT.lupus sensitive in Platelet poor plasma from Control by Coagulation assayL43362-3Cardiolipin IgG Ab [Mass/volume] in SerumL52781-2Maximum clot firmness [Length] in Blood by Thromboelastography.rotational.intrinsic coagulation system activatedL56011-0Platelet aggregation in Blood by ADP induced ATP secretion 10 umol/LL38521-1Coagulation factor VIII Ag actual/normal in Platelet poor plasma by ImmunoassayL40596-9Prothrombin IgM Ab [Units/volume] in Serum or PlasmaL5949-3aPTT.factor substitution immediately after addition of normal plasma in Platelet poor plasma from Control by Coagulation assayL52787-9Maximum lysis [Length fraction] in Blood by Thromboelastography.rotational.intrinsic coagulation system activatedL25742-8Prothrombin Fragment 1.2 [Moles/volume] in Serum or PlasmaL44950-4aPTT.factor substitution 1H post incubation with normal plasma in Platelet poor plasma from Control by Coagulation assayL40824-5von Willebrand factor (vWf) cleaving protease inhibitor [Units/volume] in Platelet poor plasmaL5998-0Platelet aggregation in Platelet rich plasma by ristocetin inducedL57763-5Activated partial thromboplastin time (aPTT).factor substitution in Platelet poor plasma by Coagulation assay --immediately after addition of normal plasma/pre addition of normal plasmaL27817-6Beta 2 glycoprotein 1 Ab [Presence] in Serum by ImmunoassayL73978-9von Willebrand factor (vWf).activity [Units/volume] in Platelet poor plasma by ImmunoassayL33894-7Prothrombin time (PT) factor substitution 1H post incubation with 1:4 normal plasma in Platelet poor plasma by Coagulation assayL33888-9aPTT.factor substitution 1H post incubation with 1:4 normal plasma in Platelet poor plasma from Control by Coagulation assayL24378-2Platelet aggregation interpretation in Platelet rich plasma Qualitative Induced by EpinephrineL43363-1Cardiolipin IgM Ab [Mass/volume] in SerumL5899-0Coagulation normal/actual in Platelet poor plasma by aPTTL3191-4Coagulation factor V inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL33525-7Thrombin time.factor substitution immediately after addition of normal plasma in Platelet poor plasma by Coagulation assayL5955-0Thrombin time in Platelet poor plasma from Control by Coagulation assayL3188-0Coagulation factor IX activity [Units/volume] in Platelet poor plasma by Chromogenic methodL3192-2Coagulation factor V activity [Units/volume] in Platelet poor plasma by Coagulation assayL34189-1Coag.surface induced.factor substitution.30M post incubation after addition of normal plasma in Platelet poor plasma by Coagulation assayL29263-1Fibrin degradation products [Presence] in Blood by AgglutinationL40702-3Fibrin monomer [Presence] in Platelet poor plasma by HemagglutinationL42772-4Fibrinogen Ag [Mass/volume] in Platelet poor plasma by NephelometryL4680-5von Willebrand factor (vWf) ristocetin cofactor [Units/volume] in Platelet poor plasmaL74217-1Fondaparinux [Mass/volume] in Platelet poor plasma by Chromogenic methodL3185-6Coagulation factor IX inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL41867-3von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasmaL5975-8Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by ImmunoassayL48595-3von Willebrand evaluation [Interpretation] in Platelet poor plasmaL88449-4Coagulation factor IX activity actual/normal in Platelet poor plasma by Chromogenic methodL5999-8Platelet aggregation in Platelet rich plasma by serotonin inducedL40595-1Prothrombin IgG Ab [Units/volume] in Serum or PlasmaL38517-9Coag.surface induced.factor substitution.2H post incubation in Platelet poor plasma by Coagulation assayL3180-7Cardiolipin Ab [Units/volume] in Serum by ImmunoassayL11568-3Phosphatidylserine IgG Ab [Presence] in SerumL31159-7Heparin anti Xa [Units/volume] in Nonbiological fluidL22758-7Plasminogen activator inhibitor 1 Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL50378-9von Willebrand factor (vWf).collagen binding activity/von Willebrand factor Ag [Ratio] in Platelet poor plasma by ImmunoassayL29991-7Fibrin+Fibrinogen fragments [Mass/volume] in Serum by Latex agglutinationL12185-5aPTT in Blood from Control by Coagulation assayL11569-1Phosphatidylserine IgM Ab [Presence] in SerumL33890-5aPTT.factor substitution 2H post incubation with normal plasma in Platelet poor plasma by Coagulation assayL74871-5Rivaroxaban [Mass/volume] in Platelet poor plasma by Chromogenic methodL3251-6Fibrin+Fibrinogen fragments [Units/volume] in Platelet poor plasma by Latex agglutinationL89366-9von Willebrand factor collagen binding adhesion inhibitor [Units/volume] in Platelet poor plasma by Chromogenic methodL85359-8Phosphatidylserine-prothrombin complex IgG Ab [Units/volume] in Serum or Plasma by ImmunoassayL85358-0Phosphatidylserine-prothrombin complex IgM Ab [Units/volume] in Serum or Plasma by ImmunoassayL6002-0Platelet factor 4 [Units/volume] in Platelet poor plasmaL72337-9Protein S Ag [Units/volume] in Platelet poor plasma by ImmunoassayL6013-7von Willebrand factor (vWf) multimers in Platelet poor plasma by ImmunoblotL75514-0Lupus anticoagulant two screening tests W Reflex [interpretation]L33356-7Prothrombin time (PT) factor substitution 1H post incubation with normal plasma in Platelet poor plasma by Coagulation assayL75510-8aPTT.lupus sensitive with 1:1 PNP (LA mix)L66759-2Heparin neutralization [Presence] in Blood by ThromboelastographyL3256-5Fibrinogen Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL5970-9Plasminogen [Units/volume] in Platelet poor plasma by Chromogenic methodL6006-1Protein C [Units/volume] in Platelet poor plasma by Chromogenic methodL68324-3von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by ImmunoassayL78522-0Platelet aggregation in Platelet rich plasma by ADP induced 5 umol/LL56021-9Platelet aggregation interpretation in Blood Qualitative by Thrombin induced ATP secretion.1 U/mLL56020-1Platelet aggregation in Blood by thrombin induced ATP secretion 5 U/mLL56009-4Platelet aggregation in Blood by collagen induced 5 ug/mLL56002-9Platelet aggregation in Blood by ADP induced ATP secretion 5 umol/LL49999-6Platelet aggregation interpretation in Platelet rich plasma by induced by CollagenL24381-6Platelet aggregation interpretation in Platelet rich plasma Qualitative Induced by ArachidonateL53221-8dRVVT in Platelet poor plasma from Control by Coagulation assayL33553-9Platelet aggregation in Platelet rich plasma by ristocetin induced 600 ug/mLL33551-3Platelet aggregation in Platelet rich plasma by ristocetin induced 1200 ug/mLL24380-8Platelet aggregation interpretation in Platelet rich plasma Qualitative Induced by RistocetinL6009-5Protein C Ag [Units/volume] in Platelet poor plasma by ImmunoassayL28657-5Coagulation factor X activated actual/normal in Platelet poor plasma by Chromogenic methodL20991-6Antithrombin [Interpretation] in Platelet poor plasmaL66755-0Maximum clot firmness [Length] in Blood by Thromboelastography --after addition of heparinaseL66754-3Clot firmness [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinaseL66752-7Clot strength in Blood by Thromboelastography --after addition of heparinaseL66750-1Clot angle in Blood by Thromboelastography --after addition of heparinaseL66753-5Clot formation [Time] in Blood by Thromboelastography --after addition of heparinaseL43734-3aPTT saline 1:1 in Platelet poor plasma by Coagulation assayL74214-8Apixaban [Mass/volume] in Platelet poor plasma by Chromogenic methodL3240-9Coagulation factor XIII coagulum dissolution [Units/volume] in Platelet poor plasma by Coagulation assayL32031-7Phosphatidylserine IgA Ab [Units/volume] in Serum by ImmunoassayL1868-9Antithrombin Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL34444-0Acarboxyprothrombin [Mass/volume] in Serum or PlasmaL5959-2Prothrombin time (PT) factor substitution immediately after addition of normal plasma in Platelet poor plasma by Coagulation assayL3179-9Bleeding time by Ivy methodL40593-6Platelet aggregation [Units/volume] in Platelet rich plasma by EPINEPHrine induced 50 umol/LL56019-3Platelet aggregation in Blood by thrombin induced ATP secretion 1 U/mLL56015-1Platelet aggregation in Blood by collagen induced ATP secretion 1 ug/mLL32033-3Phosphatidylserine IgM Ab [Units/volume] in Serum by ImmunoassayL32032-5Phosphatidylserine IgG Ab [Units/volume] in Serum by ImmunoassayL28660-9Plasminogen actual/normal in Platelet poor plasma by Chromogenic methodL38276-2aPTT 1 hour post incubation in Platelet poor plasma from Pooled by Coagulation assayL8062-2Cardiolipin Ab [Units/volume] in SerumL3175-7Antithrombin Ag [Units/volume] in Platelet poor plasma by ImmunoassayL3176-5Antithrombin [Moles/volume] in Platelet poor plasma by Chromogenic methodL3259-9Fibrinogen fragments Ag [Units/volume] in Platelet poor plasma by ImmunoassayL27815-0Coagulation factor XIII activity actual/normal in Platelet poor plasma by Chromogenic methodL24386-5Cardiolipin IgM Ab [Presence] in Serum by ImmunoassayL30322-2aPTT.factor substitution 1 hour post incubation in Platelet poor plasma by Coagulation assayL20425-5Cardiolipin IgM Ab [Interpretation] in SerumL29280-5Fibrin D-dimer [Presence] in Platelet poor plasma by Latex agglutinationL30323-0aPTT.factor substitution 1H post incubation with normal plasma in Platelet poor plasma by Coagulation assayL53570-8aPTT.lupus insensitive in Platelet poor plasma by Coagulation assayL52761-4Coag.tissue factor induced.PIVKA sensitive actual/normal in Platelet poor plasma by Coagulation assayL21027-8Platelet aggregation [Interpretation] in Platelet poor plasmaL46125-1Cardiolipin Ab [Presence] in Serum by ImmunoassayL20424-8Cardiolipin IgG Ab [Interpretation] in SerumL49865-9Coagulation factor VIII activity actual/normal in Platelet poor plasma by Chromogenic methodL5901-4Prothrombin time (PT) in Platelet poor plasma from Control by Coagulation assayL3219-3Coagulation factor X activity [Units/volume] in Platelet poor plasma by Chromogenic methodL32635-5Coagulation factor II inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL29860-4Cardiolipin Ab [Presence] in SerumL53813-2Platelet aggregation [Units/volume] in Blood by ADP inducedL33518-2Platelet aggregation in Platelet rich plasma by ADP induced High doseL30500-3Phosphatidylserine IgA Ab [Presence] in SerumL3232-6Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assayL52122-9Prothrombin time (PT) post heparin neutralization in Platelet poor plasma by Coagulation assayL52766-3aPTT in Platelet poor plasma by Coagulation assay -- after addition of protein C activator + Factor V depleted plasma/aPTTL6007-9Protein C [Units/volume] in Platelet poor plasma by Coagulation assayL49058-1aPTT in Blood drawn from CRRT circuit by Coagulation assayL5894-1Prothrombin time (PT) actual/NormalL30226-5Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasmaL5892-5Protein S [Units/volume] in Platelet poor plasma by Coagulation assayL3241-7Coagulation factor XIII coagulum dissolution at 24 hours [Presence] in Platelet poor plasma by Coagulation assayL14246-3Phosphatidylserine IgM Ab [Units/volume] in SerumL13069-0Phosphatidylserine IgA Ab [Units/volume] in SerumL33594-3Platelet factor 4 [Presence] in Platelet poor plasmaL33984-6Coagulation factor X activity actual/normal in Platelet poor plasma by Chromogenic methodL14245-5Phosphatidylserine IgG Ab [Units/volume] in SerumL6302-4Coagulation normal/actual in Platelet poor plasma by Prothrombin time (PT)L4677-1Protein S Free Ag [Units/volume] in Platelet poor plasma by ImmunoassayL40594-4Platelet aggregation [Units/volume] in Platelet rich plasma by EPINEPHrine induced 100 umol/LL66751-9Clot strength in Blood by ThromboelastographyL27183-3Cardiolipin IgG Ab [Presence] in SerumL3208-6Coagulation factor VIII activity [Units/volume] in Platelet poor plasma by Coagulation assayL49011-0Platelet aggregation [Units/volume] in Platelet rich plasma by arachidonate inducedL53622-7von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by Chromogenic methodL66745-1Clot Lysis [Length fraction] in Blood by Thromboelastography --30 minutes post maximum clot amplitudeL53814-0Platelet aggregation [Units/volume] in Blood by arachidonate inducedL56012-8Platelet aggregation interpretation in Blood Qualitative by Arachidonate induced ATP secretion.500 umol/LL52789-5Clot initiation [Time] in Blood by ThromboelastographyL52768-9Clot formation [Time] in Blood by ThromboelastographyL13488-2aPTT in Platelet poor plasma from Control by Coagulation assayL3204-5Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL50008-2Mixing studies [Interpretation] in Platelet poor plasma NarrativeL66748-5Clot angle in Blood by ThromboelastographyL52778-8Maximum clot firmness [Length] in Blood by ThromboelastographyL3174-0Antithrombin [Units/volume] in Platelet poor plasma by Chromogenic methodL49010-2Platelet aggregation [Units/volume] in Platelet rich plasma by ADP inducedL66747-7Clotting time of Blood by Heparin protamine titrationL49836-0Platelet function (closure time) [Interpretation] in Blood NarrativeL3226-8Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assayL81643-9von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasmaL46417-2Prothrombin time (PT) in Capillary blood by Coagulation assayL3210-2Coagulation factor VIII activity [Units/volume] in Platelet poor plasma by Chromogenic methodL32217-2von Willebrand factor (vWf) multimers [Presence] in Platelet poor plasmaL3270-6LMW Heparin [Units/volume] in Platelet poor plasma by Coagulation assayL27821-8Protein S Free Ag actual/normal in Platelet poor plasma by ImmunoassayL27812-7Antithrombin Ag actual/normal in Platelet poor plasma by ImmunoassayL3198-9Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assayL3218-5Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assayL13590-5Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assayL31102-7Protein S actual/normal in Platelet poor plasma by Chromogenic methodL13058-3aPTT in Platelet poor plasma by Coagulation assay --2nd specimenL24472-3Platelet function (closure time) [Time] in Blood by Collagen+Adenosine diphosphate inducedL8067-1Cardiolipin IgM Ab [Units/volume] in Serum or PlasmaL66736-0Normalized silica clotting time of Platelet poor plasmaL15179-5Fibrin D-dimer [Presence] in Platelet poor plasmaL24471-5Platelet function (closure time) [Time] in Blood by Collagen+Epinephrine inducedL48067-3Fibrin D-dimer [Mass/volume] in Platelet poor plasma by Immunoassay.FEUL3187-2Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assayL27823-4Protein S Ag actual/normal in Platelet poor plasma by ImmunoassayL43916-6Beta 2 glycoprotein 1 IgM Ab [Presence] in SerumL43915-8Beta 2 glycoprotein 1 IgA Ab [Presence] in SerumL43914-1Beta 2 glycoprotein 1 IgG Ab [Presence] in SerumL7801-4Phospholipid IgG Ab [Units/volume] in SerumL7802-2Phospholipid IgM Ab [Units/volume] in SerumL27819-2Protein C actual/normal in Platelet poor plasma by Coagulation assayL27820-0Protein C Ag actual/normal in Platelet poor plasma by ImmunoassayL8063-0Cardiolipin IgA Ab [Units/volume] in Serum or PlasmaL6012-9von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by ImmunoassayL6014-5von Willebrand factor (vWf) actual/normal in Platelet poor plasma by Aggregometry.ristocetin cofactor activityL32684-3LMW Heparin [Units/volume] in Platelet poor plasmaL40723-9Heparin Ab [Presence] in Platelet poor plasma by AggregometerL15359-3dRVVT actual/normal (normalized LA screen)L27818-4Protein C actual/normal in Platelet poor plasma by Chromogenic methodL66483-9Heparin unfractionated [Units/volume] in Platelet poor plasmaL48054-1Kaolin activated time [Units/volume] in Blood by Coagulation assayL50410-0dRVVT/dRVVT W excess phospholipid (screen to confirm ratio)L21108-6Beta 2 glycoprotein 1 IgA Ab [Units/volume] in SerumL52774-7Clotting time of Blood by Thromboelastography.rotational.extrinsic coagulation system activated.fibrinolysis suppressedL27822-6Protein S actual/normal in Platelet poor plasma by Coagulation assayL52780-4Maximum clot firmness [Length] in Blood by Thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibitedL52773-9Clotting time of Blood by Thromboelastography.rotational.extrinsic coagulation system activatedL52776-2Clotting time of Blood by Thromboelastography.rotational.intrinsic coagulation system activatedL16859-1Fibrinogen [Presence] in Platelet poor plasmaL66756-8Clot initiation [Time] in Blood by Thromboelastography --after addition of heparinaseL27816-8von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by ImmunoassayL3289-6Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assayL5076-5Cardiolipin IgA Ab [Units/volume] in Serum by ImmunoassayL75882-1Lupus anticoagulant three screening tests W Reflex [interpretation]L57838-5dRVVT W excess phospholipid (LA confirm)L75513-2dRVVT with 1:1 PNP (LA mix)L8065-5Cardiolipin IgG Ab [Units/volume] in Serum or PlasmaL6683-7Reptilase timeL5946-9aPTT.factor substitution immediately after addition of normal plasma in Platelet poor plasma by Coagulation assayL16135-6Beta 2 glycoprotein 1 IgG Ab [Units/volume] in SerumL27811-9Antithrombin actual/normal in Platelet poor plasma by Chromogenic methodL16136-4Beta 2 glycoprotein 1 IgM Ab [Units/volume] in SerumL3273-0Heparin unfractionated [Units/volume] in Platelet poor plasma by Coagulation assayL3193-0Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assayL33930-9aPTT W excess hexagonal phospholipid (StaClot LA confirm)L3287-0Phospholipid IgM Ab [Units/volume] in Serum by ImmunoassayL3286-2Phospholipid IgG Ab [Units/volume] in Serum by ImmunoassayL3282-1aPTT W excess hexagonal phase phospholipid in Platelet poor plasma by Coagulation assayL34571-0aPTT.lupus sensitive (LA screen)L20429-7Phospholipid IgM Ab [Presence] in SerumL20428-9Phospholipid IgG Ab [Presence] in SerumL44447-1Beta 2 glycoprotein 1 IgA Ab [Units/volume] in Serum or Plasma by ImmunoassayL3243-3Thrombin timeL3209-4Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assayL3181-5Cardiolipin IgG Ab [Units/volume] in Serum by ImmunoassayL44449-7Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum or Plasma by ImmunoassayL44448-9Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by ImmunoassayL3271-4LMW Heparin [Units/volume] in Platelet poor plasma by Chromogenic methodL48344-6Activated clotting time (ACT) of Platelet poor plasma by Kaolin activated timeL3182-3Cardiolipin IgM Ab [Units/volume] in Serum by ImmunoassayL52123-7aPTT post heparin neutralization in Platelet poor plasma by Coagulation assayL3173-2aPTT in Blood by Coagulation assayL5964-2Prothrombin time (PT) in Blood by Coagulation assayL48066-5Fibrin D-dimer DDU [Mass/volume] in Platelet poor plasmaL48065-7Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasmaL3184-9Activated clotting time (ACT) of Blood by Coagulation assayL46418-0INR in Capillary blood by Coagulation assayL34714-6INR in Blood by Coagulation assayL3274-8Heparin unfractionated [Units/volume] in Platelet poor plasma by Chromogenic methodL3255-7Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assayL48058-2Fibrin D-dimer [Mass/volume] in Platelet poor plasma by Immunoassay.DDUL38875-1INR in Platelet poor plasma or blood by Coagulation assayL14979-9aPTT in Platelet poor plasma by Coagulation assayL6301-6INR in Platelet poor plasma by Coagulation assayL5902-2Prothrombin time (PT)L100346-6Clotting time of Blood by Thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibitedL100347-4Clot formation [Time] in Blood by Thromboelastography.rotational.extrinsic coagulation system activated.platelets inhibitedL101253-3Thrombin generation test [Interpretation] in Platelet poor plasma NarrativeL101256-6Silica clotting time of Platelet poor plasmaL101257-4Silica clotting time W excess phospholipid actual/normal of Platelet poor plasmaL101338-2Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Chromogenic methodL101738-3Platelet aggregation in Platelet rich plasma by ristocetin induced 250 ug/mLL101739-1Platelet aggregation in Platelet rich plasma by ristocetin induced 125 ug/mLL101981-9Maximum clot strength amplitude [Length] in Blood by Thromboelastography.resonance.kaolin inducedL101997-5Clot initiation.kaolin induced [Time] in Blood by ThromboelastographyL101998-3Clot formation.kaolin induced [Time] in Blood by ThromboelastographyL102000-7Maximum clot strength amplitude [Length] in Blood by Thromboelastography.kaolin inducedL102001-5Clot initiation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinaseL102002-3Clot formation.kaolin induced [Time] in Blood by Thromboelastography^after addition of heparinaseL102003-1Reduction in kaolin induced clot strength [Length fraction] in Blood by Thromboelastography ^30 min p max clot amplitude + heparinaseL102004-9Clot angle.kaolin induced in Blood by Thromboelastography^after addition of heparinaseL103226-7Fibrin+Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutinationL103619-3Coagulation surface induced.lupus sensitive.buffer (LA control) in Platelet poor plasma by Coagulation assayL104249-8Platelet aggregation in Blood by ADP induced ATP secretion 2 umol/LL104250-6Platelet aggregation in Platelet rich plasma by collagen induced 2 ug/mLL104481-7Platelet aggregation in Plasma by EPINEPHrine induced 4 umol/LL104482-5Platelet aggregation in Plasma by arachidonate induced 1 umol/LL104690-3Bivalirudin [Mass/volume] in Platelet poor plasma by Chromogenic methodL104994-9Coagulation normal/actual in Platelet poor plasma by Coag.tissue factor induced.factor substitution.immediately after 1:1 addition of normal plasma.controlL10520-5Coagulation factor Va Ag [Presence] in Tissue by Immune stainL105271-1Platelet aggregation in Platelet rich plasma by collagen induced 190 ug/mLL105752-0Reduction in clot strength [Length fraction] in BloodL105753-8Maximum clot strength amplitude [Length] in Blood by Maximum amplitude kaolin+tissue factor induced post heparin neutralizationL105754-6Maximum clot strength amplitude [Length] in Blood by Maximum amplitude tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited post heparin neutralizationL106620-8Coagulation factor VIII activity actual/normal in Platelet poor plasma by Bovine factor X substrate + ChromogenicL106842-8Coagulation factor XIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic methodL107372-5von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM)von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM) actual/normal in Platelet poor plasma by TurbidimetryL107378-2von Willebrand factor activity.ristocetin cofactor (GPIbR) actual/normal in Platelet poor plasma by TurbidimetryL107463-2Maximum clot strength amplitude [Length] in Blood by Thromboelastography.extrinsic coagulation system activated.fibrinolysisL107529-0Maximum clot strength amplitude [Units/volume] in Blood by Thromboelastography.extrinsic coagulation system activated.fibrinolysisL107530-8Maximum clot strength amplitude [Length] in Blood by Thromboelastography.extrinsic coagulation system activatedL107531-6Maximum clot strength amplitude [Units/volume] in Blood by Thromboelastography.extrinsic coagulation system activatedL107532-4Maximum clot strength amplitude [Length] in Blood by Thromboelastography.extrinsic coagulation system activated.plateletsL107533-2Maximum clot strength amplitude [Units/volume] in Blood by Thromboelastography.extrinsic coagulation system activated.plateletsL107534-0Maximum clot strength amplitude [Length] in Blood by Thromboelastography.intrinsic coagulation system activatedL107535-7Maximum clot strength amplitude [Units/volume] in Blood by Thromboelastography.intrinsic coagulation system activatedL107536-5Maximum clot strength amplitude [Length] in Blood by Thromboelastography.intrinsic coagulation system activated.heparinL107537-3Maximum clot strength amplitude [Units/volume] in Blood by Thromboelastography.intrinsic coagulation system activated.heparinL107616-5von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM)von Willebrand factor activity.glycoprotein Ib gain of function (GPIbM) actual/normal in Platelet poor plasma by ImmunoassayL107641-3von Willebrand factor activity.GPIbM/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasma by TurbidimetryL107926-8Glycoprotein 2 IgG Ab [Presence] in Serum by ImmunofluorescenceL107927-6Glycoprotein 2 IgA Ab [Presence] in Serum by ImmunofluorescenceL13050-0Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasmaL13052-6Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assayL13059-1aPTT in Platelet poor plasma by Coagulation assay --3rd specimenL13060-9aPTT in Platelet poor plasma by Coagulation assay --4th specimenL13589-7Activated protein C resistance [Presence] in Blood by NAA with probe detectionL13593-9Platelet aggregation in Platelet rich plasma by prostaglandin inducedL16860-9Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by ImmunoassayL16861-7Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by ImmunoassayL16862-5Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by ImmunoassayL16863-3Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by ImmunoassayL16864-1Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by ImmunoassayL16865-8Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by ImmunoassayL16866-6Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by ImmunoassayL17451-6Phosphatidylglycerol IgA Ab [Presence] in SerumL17452-4Phosphatidylglycerol IgG Ab [Presence] in SerumL17453-2Phosphatidylglycerol IgM Ab [Presence] in SerumL17455-7Phosphatidylinositol IgG Ab [Presence] in SerumL17467-2Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by ImmunoassayL19140-3Phospholipid Ab [Presence] in SerumL1983-6Bradykinin [Mass/volume] in Serum or PlasmaL2040-4Cardiolipin [Mass/volume] in SerumL20484-2Cardiolipin IgG Ab [Titer] in SerumL20669-8Cardiolipin IgA Ab [Titer] in SerumL21001-3Coagulation factor VIII [Interpretation] in SpecimenL21002-1Fibrinogen [Interpretation] in Platelet poor plasmaL21032-8Thrombin time [Interpretation] in Blood by Coagulation assayL21464-3Plasminogen activator urokinase type [Presence] in TissueL2278-0Fibrinopeptide B [Mass/volume] in SerumL2279-8Fibrinopeptide A [Mass/volume] in Peritoneal fluidL25377-3Recalcification time in Platelet poor plasma from Control by Coagulation assayL27814-3Coagulation factor VII+Coagulation factor X actual/normal in Platelet poor plasma by Coagulation assayL27990-1Fibrinogen fragments [Mass/volume] in Platelet poor plasma by Latex agglutinationL27991-9Fibrinogen fragments [Mass/volume] in Urine by Latex agglutinationL28652-6Heparinoid [Units/volume] in Platelet poor plasma by Chromogenic methodL28658-3Plasmin inhibitor actual/normal in Platelet poor plasma by ImmunoassayL30086-3Coagulation factor IX inhibitor [Presence] in Platelet poor plasma by Coagulation assayL30321-4aPTT.factor substitution 1 hour post incubation in Platelet poor plasma from Control by Coagulation assayL31256-1Beta 2 glycoprotein 1 Ab [Presence] in SerumL31561-4Phospholipid IgA Ab [Units/volume] in SerumL3183-1Clotting time of Blood by Lee White methodL3195-5Coagulation factor V Ag actual/normal in Platelet poor plasma by ImmunoassayL3200-3Coagulation factor VII activity actual/normal [Molar ratio] in Platelet poor plasma by Coagulation assayL3202-9Coagulation factor VII+Acarboxy Ag [Units/volume] in Platelet poor plasma by ImmunoassayL3203-7Coagulation factor VII+Acarboxy Ag activity actual/normal in Platelet poor plasma by ImmunoassayL3205-2Coagulation factor VIII Ab [Units/volume] in Platelet poor plasma by ImmunoassayL3207-8Coagulation factor VIII inhibitor [Presence] in Platelet poor plasma by Chromogenic methodL3212-8Coagulation factor VIII Activity.Xa activator [Units/volume] in Platelet poor plasma by Chromogenic methodL3215-1Coagulation factor VIII Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3222-7Coagulation factor X+Acarboxy Ag [Units/volume] in Platelet poor plasma by ImmunoassayL3223-5Coagulation factor X+Acarboxy Ag actual/normal in Platelet poor plasma by ImmunoassayL3229-2Coagulation factor XI Ag actual/normal in Platelet poor plasma by ImmunoassayL3233-4Coagulation factor XII activity [Units/volume] in Platelet poor plasma by Chromogenic methodL3235-9Coagulation factor XII Ag actual/normal in Platelet poor plasma by ImmunoassayL3236-7Coagulation factor XIII inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL3242-5Recalcification time in Platelet poor plasma by Coagulation assayL3245-8Clot Retraction [Time] in Blood by Coagulation assayL3248-2Fibrin fragments Ag [Units/volume] in Platelet poor plasma by ImmunoassayL3249-0Fibrin fragments [Identifier] in Platelet poor plasma by ImmunoelectrophoresisL3253-2Fibrin.soluble [Units/volume] in Platelet poor plasma by Chromogenic methodL3254-0Fibrin.soluble [Units/volume] in Serum by Coagulation assayL3260-7Fibrinopeptide B beta (1-14) Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3261-5Fibrinopeptide B beta (1-42) Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3262-3Fibrinopeptide B beta (15-42) Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3263-1Fibrinopeptide B beta (43-47) Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3264-9Fibrinopeptide A Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3265-6Fibrinopeptide B Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL3272-2LMW Heparin [Mass/time] in 24 hour UrineL3275-5Heparin unfractionated [Mass/time] in 24 hour UrineL3276-3Kininogen HMW [Units/volume] in Platelet poor plasma by Coagulation assayL3277-1Kininogen HMW [Mass/volume] in Platelet poor plasma by ImmunoassayL3279-7Kininogen LMW [Mass/volume] in Platelet poor plasma by ImmunoassayL3280-5Kininogen LMW [Mass/volume] in Serum by ImmunoassayL3285-4Phospholipid Ab [Units/volume] in Serum by ImmunoassayL33306-2Phosphatidate Ab [Presence] in SerumL33307-0Phosphatidylcholine Ab [Presence] in SerumL33309-6Phosphatidylinositol Ab [Presence] in SerumL33520-8Platelet aggregation in Platelet rich plasma by collagen induced High doseL33524-0Clot Lysis [Time] in Control Platelet poor plasma by Coagulation assayL33530-7Platelet aggregation in Control Platelet rich plasma by EPINEPHrine inducedL33550-5Platelet aggregation in Platelet rich plasma by ristocetin induced 1500 ug/mLL33552-1Platelet aggregation in Platelet rich plasma by ristocetin induced 900 ug/mLL33554-7Platelet aggregation in Platelet rich plasma by ristocetin induced 300 ug/mLL33589-3Phosphatidylinositol Ab [Units/volume] in Serum by ImmunoassayL33611-5Phosphatidylethanolamine Ab [Units/volume] in SerumL33670-1Platelet aggregation [Time] in Platelet rich plasma by collagen induced lag High doseL33671-9Platelet aggregation [Time] in Control Platelet rich plasma by collagen induced lag High doseL33672-7Platelet aggregation in Platelet rich plasma by ristocetin+Control PPP inducedL33674-3Platelet aggregation in Platelet poor plasma by ristocetin+Control PRP inducedL33881-4Prothrombin time (PT) factor substitution immediately after 1:4 addition of normal plasma in Platelet poor plasma from Control by Coagulation assayL33883-0Prothrombin time (PT) factor substitution 1H post incubation with 1:4 normal plasma in Platelet poor plasma from Control by Coagulation assayL33885-5Prothrombin time (PT) factor substitution 2H post incubation with 1:4 normal plasma in Platelet poor plasma by Coagulation assayL33886-3Prothrombin time (PT) factor substitution 2H post incubation with 1:4 normal plasma in Platelet poor plasma from Control by Coagulation assayL33889-7aPTT.factor substitution 2H post incubation with 1:4 normal plasma in Platelet poor plasma from Control by Coagulation assayL33895-4Prothrombin time (PT) factor substitution 2 hours post incubation in Platelet poor plasma by Coagulation assayL34682-5Prothrombin time (PT) factor substitution immediately after addition of factor V depleted plasma in Platelet poor plasma by Coagulation assayL34683-3aPTT.factor substitution immediately after addition of factor IX depleted plasma in Platelet poor plasma by Coagulation assayL34684-1aPTT.factor substitution immediately after addition of factor XIII depleted plasma in Platelet poor plasma by Coagulation assayL34685-8Prothrombin time (PT) factor substitution immediately after addition of factor X depleted plasma in Platelet poor plasma by Coagulation assayL34686-6Coag.tissue factor induced.factor substitution.immediately after addition of factor II depleted plasma in Platelet poor plasma by Coagulation assayL34687-4aPTT.factor substitution immediately after addition of factor XI depleted plasma in Platelet poor plasma by Coagulation assayL34688-2aPTT.factor substitution immediately after addition of factor XII depleted plasma in Platelet poor plasma by Coagulation assayL35373-0Platelet aggregation in Platelet rich plasma from Donor by XXX inducedL38520-3Capillary fragility [Presence]L38523-7Fibrinopeptide A [Mass/volume] in UrineL38898-3Fibrin D-dimer [Titer] in Platelet poor plasmaL39556-6Coagulation factor X inhibitor [Presence] in Platelet poor plasma by Coagulation assayL40087-9Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours pre XXX challengeL40090-3Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 hour post XXX challengeL40091-1Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challengeL40092-9Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --2 hours post XXX challengeL40093-7Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --3 hours post XXX challengeL40094-5Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --4 hours post XXX challengeL40095-2Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --6 hours post XXX challengeL40096-0Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --8 hours post XXX challengeL40097-8Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --12 hours post XXX challengeL40098-6Prothrombin time (PT) in Platelet poor plasma by Coagulation assay --1 day post XXX challengeL40099-4aPTT in Platelet poor plasma by Coagulation assay --2 hours pre XXX challengeL40101-8aPTT in Platelet poor plasma by Coagulation assay --30 minutes post XXX challengeL40102-6aPTT in Platelet poor plasma by Coagulation assay --1 hour post XXX challengeL40103-4aPTT in Platelet poor plasma by Coagulation assay --1.5 hours post XXX challengeL40104-2aPTT in Platelet poor plasma by Coagulation assay --2 hours post XXX challengeL40105-9aPTT in Platelet poor plasma by Coagulation assay --3 hours post XXX challengeL40106-7aPTT in Platelet poor plasma by Coagulation assay --4 hours post XXX challengeL40107-5aPTT in Platelet poor plasma by Coagulation assay --6 hours post XXX challengeL40108-3aPTT in Platelet poor plasma by Coagulation assay --8 hours post XXX challengeL40109-1aPTT in Platelet poor plasma by Coagulation assay --12 hours post XXX challengeL40110-9aPTT in Platelet poor plasma by Coagulation assay --1 day post XXX challengeL40111-7aPTT in Platelet poor plasma by Coagulation assay --18 hours post XXX challengeL40458-2Prothrombin time (PT) factor substitution immediately after addition of factor VIII depleted plasma in Platelet poor plasma by Coagulation assayL40686-8Platelet factor 3 [Units/volume] in Platelet rich plasmaL40744-5Factor inhibitor XXX [Presence] in Platelet poor plasma by Coagulation assayL42638-7Prothrombin time (PT) in Platelet poor plasma by Coagulation assayL42727-8Fibrin D-dimer [Mass/volume] in Cerebral spinal fluid by Latex agglutinationL42729-4Cardiolipin IgA Ab B2GP1 dependent [Multiple of the median] in SerumL42730-2Cardiolipin IgA Ab B2GP1 independent [Multiple of the median] in SerumL42731-0Cardiolipin IgG Ab B2GP1 dependent [Multiple of the median] in SerumL42732-8Cardiolipin IgG Ab B2GP1 independent [Multiple of the median] in SerumL42733-6Cardiolipin IgM Ab B2GP1 dependent [Multiple of the median] in SerumL42734-4Cardiolipin IgM Ab B2GP1 independent [Multiple of the median] in SerumL42739-3Phosphatidylcholine IgA Ab B2GP1 dependent [Multiple of the median] in SerumL42740-1Phosphatidylcholine IgA Ab B2GP1 independent [Multiple of the median] in SerumL42741-9Phosphatidylcholine IgG Ab B2GP1 dependent [Multiple of the median] in SerumL42742-7Phosphatidylcholine IgG Ab B2GP1 independent [Multiple of the median] in SerumL42743-5Phosphatidylcholine IgM Ab B2GP1 dependent [Multiple of the median] in SerumL42744-3Phosphatidylcholine IgM Ab B2GP1 independent [Multiple of the median] in SerumL42745-0Phosphatidylethanolamine IgA Ab B2GP1 dependent [Multiple of the median] in SerumL42746-8Phosphatidylethanolamine IgA Ab B2GP1 independent [Multiple of the median] in SerumL42747-6Phosphatidylethanolamine IgG Ab B2GP1 dependent [Multiple of the median] in SerumL42748-4Phosphatidylethanolamine IgG Ab B2GP1 independent [Multiple of the median] in SerumL42749-2Phosphatidylethanolamine IgM Ab B2GP1 dependent [Multiple of the median] in SerumL42750-0Phosphatidylethanolamine IgM Ab B2GP1 independent [Multiple of the median] in SerumL42751-8Phosphatidylserine IgA Ab B2GP1 dependent [Multiple of the median] in SerumL42752-6Phosphatidylserine IgA Ab B2GP1 independent [Multiple of the median] in SerumL42753-4Phosphatidylserine IgG Ab B2GP1 dependent [Multiple of the median] in SerumL42754-2Phosphatidylserine IgG Ab B2GP1 independent [Multiple of the median] in SerumL42755-9Phosphatidylserine IgM Ab B2GP1 dependent [Multiple of the median] in SerumL42756-7Phosphatidylserine IgM Ab B2GP1 independent [Multiple of the median] in SerumL43636-0Plasminogen activator tissue type [Presence] in Platelet poor plasma by Chromogenic methodL45274-8Low molecular weight heparin induced platelet Ab [Presence] in SerumL4669-8Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasmaL47285-2Heparin cofactor II Ag [Units/volume] in Platelet poor plasmaL48022-8aPTT.lupus sensitive actual/normal (normalized LA screen)L48592-0Fibrin+Fibrinogen fragments [Titer] in Platelet poor plasma by Latex agglutinationL49008-6Clot Retraction [Volume Fraction] in BloodL49485-6Platelet aggregation in Platelet rich plasma by ristocetin induced 1800 ug/mLL49639-8Protein C/Coagulation factor X [Mass Ratio] in Platelet poor plasmaL49640-6Protein S Ag/Coagulation factor X Ag [Mass Ratio] in Platelet poor plasma by Coagulation assayL50746-7Hirudin [Units/volume] in Platelet poor plasma by Chromogenic methodL50944-8Platelet aggregation interpretation in Platelet rich plasma Qualitative by Adenosine diphosphate induced.20 umol/LL50951-3Phosphoserine IgA Ab [Presence] in Serum or PlasmaL50952-1Phosphoserine IgG Ab [Presence] in Serum or PlasmaL50953-9Phosphoethanolamine IgM Ab [Presence] in Serum or PlasmaL50954-7Phosphoethanolamine IgG Ab [Presence] in Serum or PlasmaL50955-4Phosphoserine IgM Ab [Presence] in Serum or PlasmaL51626-0Prothrombin time (PT) factor substitution with 1:4 normal plasma 1H post incubation separate tubes in Platelet poor plasma by Coagulation assayL51728-4Platelet aggregation interpretation in Platelet rich plasma Qualitative by Adenosine diphosphate induced.10 umol/LL51802-7Phosphatidylserine IgM Ab [Titer] in Serum by ImmunofluorescenceL52120-3Prothrombin time (PT) factor substitution with normal plasma 1H post incubation separate tubes in Platelet poor plasma by Coagulation assayL52129-4INR post heparin neutralization in Platelet poor plasma by Coagulation assayL52751-5aPTT.factor sensitive in Platelet poor plasma by Coagulation assayL52752-3Coag.tissue factor induced.PIVKA insensitive actual/normal in Capillary blood by Coagulation assayL52753-1Coag.tissue factor induced.PIVKA insensitive actual/normal in Platelet poor plasma by Coagulation assayL52759-8Prekallikrein (Fletcher Factor) activity actual/normal in Platelet poor plasma by Coagulation assayL52760-6Coag.tissue factor induced.PIVKA sensitive actual/normal in Capillary blood by Coagulation assayL52769-7Clot formation [Time] in Blood by Thromboelastography.rotational.extrinsic coagulation system activated.fibrinolysis suppressedL52775-4Clotting time of Blood by Thromboelastography.rotational.intrinsic coagulation system activated.heparin insensitiveL52779-6Maximum clot firmness [Length] in Blood by Thromboelastography.rotational.extrinsic coagulation system activated.fibrinolysis suppressedL52782-0Maximum clot firmness [Length] in Blood by Thromboelastography.rotational.intrinsic coagulation system activated.heparin insensitiveL52783-8Maximum clot firmness [Length] in Blood by Thromboelastography.rotational.extrinsic coagulation system activatedL52788-7Maximum lysis [Length fraction] in Blood by Thromboelastography.rotational.intrinsic coagulation system activated.heparin insensitiveL53230-9Prothrombin time (PT) factor substitution immediately after 1:4 addition of normal plasma in Platelet poor plasma by Coagulation assayL53563-3Platelet aggregation in Platelet rich plasma by ADP induced 20 umol/mLL53564-1Platelet aggregation in Platelet rich plasma by ADP induced 50 umol/mLL53565-8Platelet aggregation in Platelet rich plasma by ADP induced 100 umol/mLL53566-6Platelet aggregation in Platelet rich plasma by collagen induced 8.0 ug/mLL53569-0Platelet aggregation in Platelet rich plasma by ristocetin induced 800 ug/mLL5369-4Streptokinase Ab [Units/volume] in SerumL54207-6aPTT.factor substitution immediately after addition of factor V depleted plasma in Platelet poor plasma by Coagulation assayL54208-4aPTT.factor substitution immediately after addition of factor V depleted plasma+APC in Platelet poor plasma by Coagulation assayL55202-6aPTT.factor substitution 5 minutes post incubation after addition of normal plasma in Platelet poor plasma by Coagulation assayL55203-4aPTT.factor substitution 5 minutes post incubation after addition of normal plasma in Platelet poor plasma from Control by Coagulation assayL55344-6Platelet aggregation in Platelet rich plasma by ristocetin induced 1000 ug/mLL55347-9Coagulation ecarin induced in Blood by Coagulation assayL55353-7Hirudin [Mass/volume] in Platelet poor plasma by Chromogenic methodL55772-8Cardiolipin IgG Ab [Multiple of the median] in SerumL55773-6Cardiolipin IgM Ab [Multiple of the median] in SerumL55795-9Phosphatidylserine IgG Ab [Multiple of the median] in SerumL55796-7Phosphatidylserine IgM Ab [Multiple of the median] in SerumL55797-5Platelet aggregation interpretation in Platelet rich plasma Qualitative by Adenosine diphosphate induced.2.5 umol/LL55798-3Platelet aggregation interpretation in Platelet rich plasma Qualitative by Adenosine diphosphate induced.5 umol/LL55799-1Platelet aggregation interpretation in Platelet rich plasma Qualitative by Ristocetin induced.1125 mg/LL55800-7Platelet aggregation interpretation in Platelet rich plasma Qualitative by Ristocetin induced.1000 mg/LL55801-5Platelet aggregation interpretation in Platelet rich plasma Qualitative by Ristocetin induced.500 mg/LL56003-7Platelet aggregation interpretation in Blood Qualitative by Adenosine diphosphate induced ATP secretion.10 umol/LL56004-5Platelet aggregation interpretation in Blood Qualitative by Adenosine diphosphate induced ATP secretion.5 umol/LL56016-9Platelet aggregation interpretation in Blood Qualitative by Collagen induced ATP secretion.1 ug/mLL56017-7Platelet aggregation interpretation in Blood Qualitative by Collagen induced ATP secretion.5 ug/mLL56018-5Platelet aggregation interpretation in Blood Qualitative by Thrombin induced ATP secretion.5 U/mLL56784-2Fibrinogen fragments [Mass/volume] in UrineL57440-0Platelet Ab [Presence] in Serum by ImmunofluorescenceL57839-3Activated clotting time (ACT) of Platelet poor plasma from Control by Kaolin activated timeL5891-7Protein S+Acarboxy Ag [Units/volume] in Platelet poor plasma by ImmunoassayL5947-7aPTT.factor substitution 20M post incubation with normal plasma in Platelet poor plasma from Control by Coagulation assayL5957-6Coag.tissue factor induced.factor substitution.20M post incubation after addition of normal plasma in Platelet poor plasma by Coagulation assayL5958-4Coag.tissue factor induced.factor substitution.20M post incubation after addition of normal plasma in Platelet poor plasma from Control by Coagulation assayL5967-5Plasmin inhibitor Ag [Units/volume] in Platelet poor plasma by ImmunoassayL5969-1Plasmin-plasmin inhibitor complex [Mass/volume] in Platelet poor plasma by ImmunoassayL5972-5Plasminogen activator tissue type Ag [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasisL5977-4Plasminogen activator inhibitor 2 Ag [Mass/volume] in Platelet poor plasma by ImmunoassayL5978-2Plasminogen activator inhibitor 2 [Units/volume] in Platelet poor plasma by Chromogenic methodL5981-6Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by ImmunoassayL5982-4Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --20 minutes post venistasisL5983-2Plasminogen activator tissue type-Plasminogen activator inhibitor 1 complex [Mass/volume] in Platelet poor plasma by Immunoassay --10 minutes post venistasisL5984-0Plasminogen activator urokinase type [Units/volume] in UrineL5985-7Plasminogen activator urokinase type [Units/volume] in Platelet poor plasmaL5988-1Plasminogen activator tissue type [Mass/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasisL5989-9Plasminogen activator tissue type [Units/volume] in Platelet poor plasma by Chromogenic method --10 minutes post venistasisL5994-9Platelet aggregation in Platelet rich plasma by calcium ionophore inducedL5997-2Platelet aggregation in Platelet rich plasma by norepinephrine inducedL6000-4Platelet aggregation [Units threshold] in Platelet rich plasma by thrombin inducedL6001-2Platelet factor 3 [Units/volume] in Platelet poor plasmaL6004-6Prekallikrein (Fletcher Factor) [Mass/volume] in Platelet poor plasma by Chromogenic methodL6008-7Protein C+Acarboxy Ag [Units/volume] in Platelet poor plasma by ImmunoassayL6011-1Protein C cofactor [Units/volume] in Platelet poor plasmaL61189-7INR in Platelet poor plasma from Fetus by Coagulation assayL61190-5Prothrombin time (PT) in Platelet poor plasma from Fetus by Coagulation assayL61191-3aPTT in Platelet poor plasma from Fetus by Coagulation assayL6303-2dRVVT in Platelet poor plasma by Coagulation assayL66749-3Circulatory assist status [Identifier]L66757-6Clot lysis estimate [Percentile] by ThromboelastographyL66758-4Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60M post maximum clot amplitudeL67566-0aPTT.factor substitution with normal plasma 2H post incubation separate tubes in Platelet poor plasma by Coagulation assayL68325-0Thrombin time actual/NormalL68326-8Reptilase time actual/NormalL68969-5Relative activated clotting time (ACT) of Platelet poor plasma by Kaolin induced without excess phospholipidsL68979-4Rivaroxaban [Units/volume] in Platelet poor plasma by Chromogenic methodL68980-2Dabigatran [Units/volume] in Platelet poor plasma by Chromogenic methodL68981-0Argatroban [Units/volume] in Platelet poor plasma by Chromogenic methodL69423-2Rosner index in Platelet poor plasma by Coagulation assayL75507-4aPTT.lupus sensitive W excess phospholipid percent correctionL75512-4dRVVT with 1:1 PNP actual/normal (normalized LA mix)L75883-9dRVVT W excess hexagonal phospholipid (STA-StaClot confirm)L75913-4dRVVT W excess hexagonal phospholipid/Normal (StaClot LA confirm)L75914-2aPTT W hexagonal phospholipid/Normal (StaClot LA confirm)L76020-7Delta dRVVT [Time] in Platelet poor plasma by Coagulation assayL76021-5Delta aPTT [Time] in Platelet poor plasma by Coagulation assayL77161-8Prothrombin activity [Units/volume] in Platelet poor plasma by Coagulation assay --immediately after addition of factor II depleted plasmaL77683-1Thrombin activatable fibrinolysis inhibitor [Units/volume] in Platelet poor plasma by Chromogenic methodL7800-6Phospholipid Ab [Units/volume] in SerumL78519-6Platelet aggregation in Platelet rich plasma by ADP induced 2 umol/LL78520-4Platelet aggregation in Platelet rich plasma by ADP induced 2.5 umol/LL78521-2Platelet aggregation in Platelet rich plasma by ADP induced 4 umol/LL78523-8Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 100 umol/LL78524-6Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 6 umol/LL78525-3Platelet aggregation in Platelet rich plasma by arachidonate induced 1.6 mmol/LL78526-1Platelet aggregation in Platelet rich plasma by collagen induced 1.25 ug/mlL78527-9Platelet aggregation in Platelet rich plasma by collagen induced 5 ug/mLL78528-7Platelet aggregation in Platelet rich plasma by ristocetin induced 1.25 mg/mlL78685-5Platelet aggregation [Units/volume] in Blood by collagen inducedL78686-3Platelet aggregation [Units/volume] in Blood by ristocetin induced High doseL78687-1Platelet aggregation [Units/volume] in Blood by thrombin receptor activating peptide-6 inducedL78688-9Platelet aggregation [Units/volume] in Blood by adenosine diphosphate+prostaglandin E1 inducedL78739-0Platelet aggregation [Units/volume] in Blood by ristocetin induced Low doseL79130-1Platelet aggregation in Platelet rich plasma by ristocetin induced 500 ug/mLL79188-9Platelet aggregation in Platelet rich plasma by ADP induced 10 umol/LL80202-5Clotting time of depleted plasma with 1:1 phospholipid by Coagulation assay --after addition of factor X activatedL80603-4Coagulation factor XI inhibitor [Presence] in Platelet poor plasma by Coagulation assayL80658-8Activated clotting time (ACT) of Blood induced by Diatomaceous earthL80892-3Heparin unfractionated [Units/volume] in Blood by Heparin protamine titrationL80893-1Projected heparin concentration to reach target ACT [Units/volume] in Blood by calculationL81123-2Coagulation factor VII inhibitor [Presence] in Platelet poor plasma by Coagulation assayL81124-0Coagulation factor V inhibitor [Presence] in Platelet poor plasma by Coagulation assayL81125-7Platelet aggregation interpretation in Platelet poor plasma Qualitative by Aggregometry.ristocetin inhibitorL81638-9Clotting time of Capillary blood by Sukharev methodL81639-7Heparin dose response slope in Blood by Coagulation assayL82792-3Clot density in Platelet poor plasmaL82793-1Clot size [Length] in Platelet poor plasma --30 minutes post incubationL82794-9Spontaneous clot formation [Time] in Platelet poor plasmaL82795-6Clot growth mean [Velocity] Platelet poor plasmaL82796-4Stationary clot growth mean [Velocity] Platelet poor plasmaL82797-2Initial clot growth [Velocity] in Platelet poor plasmaL82798-0Clot formation lag time in Platelet poor plasmaL85818-3Clot formation+Clotting time of Blood by ThromboelastographyL85819-1Clot firmness reduction [Length fraction] in Blood by Thromboelastography --60 min p max clot amplitude + heparinaseL85820-9Clot firmness reduction [Length fraction] in Blood by Thromboelastography --30 min p max clot amplitude + heparinaseL87403-2Platelet aggregation in Platelet rich plasma by ristocetin induced 750 ug/mLL88893-3Coag.tissue factor induced.PIVKA insensitive in Platelet poor plasma by Coagulation assayL89367-7von Willebrand factor.ristocetin cofactor inhibitor [Units/volume] in Platelet poor plasma by Coagulation assayL90919-2Coagulation factor VIII.recombinant.bound/von Willebrand factor (vWf) Ag in Plasma by ImmunoassayL91104-0aPTT.factor substitution with 1:1 Pooled Normal Plasma in Platelet poor plasma by Coagulation assayL91119-8aPTT.factor substitution immediately after 1:1 addition of normal plasma in Platelet poor plasma by Coagulation assayL91120-6Antithrombin in Platelet poor plasma by Chromo.no addition of heparinL91125-5Maximum clot strength amplitude [Length] in Blood by Thromboelastography.resonance.kaolin induced.after addition of heparinaseL91126-3Maximum clot strength amplitude [Length] in Blood by Thromboelastography.resonance.activator F inducedL91127-1Maximum clot strength amplitude [Length] in Blood by Thromboelastography.resonance.adenosine diphosphate inducedL91128-9Clot strength [Length fraction] in Blood by Thromboelastography.platelet adenosine diphosphate receptor inhibitedL91129-7Clot strength [Length fraction] in Blood by Thromboelastography.adenosine diphosphate inducedL91556-1Fibrin D-dimer [Mass/volume] in Blood by Immunoassay.DDUL92891-1Coagulation.INR goal in Platelet poor plasma by Prothrombin time (PT)L93234-3dRVVT post heparin neutralization in Platelet poor plasma by Coagulation assayL93235-0aPTT.lupus sensitive post heparin neutralization in Platelet poor plasma by Coagulation assayL93236-8aPTT.lupus sensitive.excess phospholipid post heparin neutralization in Platelet poor plasma by Coagulation assayL93237-6aPTT.lupus sensitive.excess phospholipid post heparin neutralization actual/normal in Platelet poor plasma by Coagulation assayL93238-4dRVVT excess phospholipid post heparin neutralization in Platelet poor plasma by Coagulation assayL93239-2dRVVT excess phospholipid post heparin neutralization actual/normal in Platelet poor plasma by Coagulation assayL93240-0dRVVT factor substitution immediately after 1:1 addition of normal plasma and heparin neutralization in Platelet poor plasma by Coagulation assayL93371-3von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic methodL93408-3Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 10 umol/LL93409-1Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 5 umol/LL93410-9Platelet aggregation in Platelet rich plasma by ristocetin induced 5 ug/mLL93450-5Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic methodL93702-9Platelet aggregation in Platelet rich plasma by ristocetin induced 15 ug/mLL93748-2Fibrin monomer [Mass/volume] in Platelet poor plasma by ImmunoassayL94187-2Platelet aggregation [Interpretation] in Platelet rich plasmaL94269-8Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 50 umol/LL94555-0dRVVT/dRVVT.excess phospholipid [Ratio] in Platelet poor plasma by Coagulation assay --post DOAC neutralizationL94556-8dRVVT excess phospholipid post DOAC neutralization in Platelet poor plasma by Coagulation assayL94557-6dRVVT post DOAC neutralization in Platelet poor plasma by Coagulation assayL94577-4Maximum clot strength amplitude [Length] in Blood by Thromboelastography.resonance.arachidonate inducedL94578-2Clot strength [Length fraction] in Blood by Thromboelastography.platelet thromboxane A2 receptor inhibitedL94579-0Clot strength [Length fraction] in Blood by Thromboelastography.arachidonate inducedL95122-8Coagulation factor VIII inhibitor [Interpretation] in Platelet poor plasma by Chromogenic methodL95241-6Platelet aggregation in Platelet rich plasma by ADP induced 0.6 umol/LL95242-4Platelet aggregation in Platelet rich plasma by ADP induced 1.2 umol/LL95243-2Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 0.5 umol/LL95244-0Platelet aggregation in Platelet rich plasma by EPINEPHrine induced 1 umol/LL95245-7Platelet aggregation in Platelet rich plasma by ristocetin induced 375 ug/mLL96260-5Prothrombin time (PT) factor substitution 2H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assayL96261-3Prothrombin time (PT) factor substitution 1H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assayL96262-1Coag.tissue factor induced.factor substitution.immediately after 1:1 addition of normal plasma in Platelet poor plasma by Coagulation assayL96263-9aPTT.lupus sensitive.factor substitution 2H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assayL96264-7aPTT.lupus sensitive.factor substitution 1H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assayL96265-4aPTT.factor substitution 2H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assayL96266-2aPTT.factor substitution 1H post incubation with 1:1 normal plasma in Platelet poor plasma by Coagulation assayL96267-0Delta Coagulation [Time] in Platelet poor plasma by aPTT W excess hexagonal phase phospholipidL96282-9Coagulation factor XII inhibitor [Presence] in Platelet poor plasma by Coagulation assayL96454-4Coagulation factor II inhibitor [Presence] in Platelet poor plasma by Coagulation assayL96680-4Activated clotting time (ACT) of Blood by Microviscometry.diatomaceous earth inducedL96681-2Activated clotting time (ACT) of Blood by Microviscometry.diatomaceous earth and clay inducedL96682-0Activated clotting time (ACT) of Blood by Microviscometry.glass bead inducedL96683-8Activated clotting time (ACT) of BloodL96684-6Activated clotting time (ACT) of Blood by Microviscometry.kaolin inducedL96691-1Coagulation viscoelastic tracing in Blood DocumentL96692-9Platelet-induced clot retraction in Blood by Microviscometry.glass bead inducedL96693-7Platelet-induced clot retraction in BloodL96694-5Rate of fibrin formation [Units] in Blood by Microviscometry.diatomaceous earth inducedL96695-2Rate of fibrin formation [Units] in Blood by Microviscometry.diatomaceous earth and clay inducedL96696-0Rate of fibrin formation [Units] in Blood by Microviscometry.glass bead inducedL96697-8Rate of fibrin formation [Units] in BloodL96698-6Rate of fibrin formation [Units] in Blood by Microviscometry.kaolin inducedL96702-6Clot initiation.kaolin induced [Time] in Blood by USL96703-4Clot initiation.kaolin induced/Clot initiation.kaolin induced post heparin neutralization [Time Ratio] in Blood by calculationL96704-2Clot initiation.kaolin induced [Time] in Blood by US --post heparin neutralizationL96705-9Clot stiffness reduction percent due to fibrinolysis in Blood by calculationL96706-7Clot stiffness.platelet contribution (elasticity) in Blood by calculationL96707-5Clot stiffness.fibrinogen contribution.tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited (elasticity) in Blood by US --post heparin neutralizationL96708-3Clot stiffness.tissue factor induced (elasticity) in Blood by US --post heparin neutralizationL97005-3Maximum clot strength amplitude [Length] in Blood by Thromboelastography.resonance.kaolin.tissue factor inducedL97006-1Maximum clot strength amplitude [Length] in Blood by Thromboelastography.kaolin.tissue factor inducedL97007-9Clot initiation [Time] in BloodL97008-7Clot initiation [Time] in Blood by Thromboelastography.kaolin.tissue factor inducedL97009-5Activated clotting time (ACT) of Blood by Thromboelastography.kaolin.tissue factor inducedL97010-3Clot formation [Time] in Blood by Thromboelastography.kaolin.tissue factor inducedL97011-1Clot angle in Blood by Thromboelastography.kaolin.tissue factor inducedL97012-9Reduction in clot strength [Length fraction] in Blood by Thromboelastography.kaolin.tissue factor induced --30 minutes post maximum clot amplitudeL97013-7Reduction in clot strength [Length fraction] in Blood by Thromboelastography.resonance.kaolin induced --30 minutes post maximum clot amplitudeL97014-5Maximum clot strength amplitude [Length] in Blood by Thromboelastography.resonance.tissue factor induced with platelet glycoprotein IIb-IIIa receptor inhibitedL97015-2Maximum clot strength amplitude [Length] in Blood by Thromboelastography.Tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibitedL97016-0Fibrinogen [Mass/volume] in Blood by calculationL97017-8Maximum clot strength amplitude [Length] in Blood by Thromboelastography.kaolin induced.after addition of heparinaseL97018-6Maximum clot strength amplitude [Length] in Blood by Thromboelastography.activator F inducedL97019-4Maximum clot strength amplitude [Length] in Blood by Thromboelastography.adenosine diphosphate inducedL97020-2Maximum clot strength amplitude [Length] in Blood by Thromboelastography.arachidonate inducedL97021-0Reduction in clot strength [Length fraction] in Blood by Thromboelastography.kaolin induced --30 minutes post maximum clot amplitudeL97022-8Clot strength [Length fraction] in Blood by Thromboelastography.arachidonate inhibitedL97641-5dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assay --post DOAC neutralizationL97642-3dRVVT/dRVVT.excess phospholipid [Ratio] normalized in Platelet poor plasma by Coagulation assayL97910-4Endogenous thrombin potential [Area under the curve] in Platelet poor plasma by Chromogenic methodL97911-2Endogenous thrombin potential [Area under the curve] in Platelet poor plasma by Chromogenic method --after addition of factor VIII AbL97912-0Thrombin peak [Molar amount] in Platelet poor plasma by Chromogenic methodL97913-8Thrombin peak [Molar amount] in Platelet poor plasma by Chromogenic method --after addition of factor VIII AbL97914-6Time to thrombin peak in Platelet poor plasma by Chromogenic methodL97990-6von Willebrand factor (vWf) cleaving protease actual/normal in Platelet poor plasma by ImmunoassayL99761-9Clot initiation [Time] in Blood by Thromboelastography.resonance.kaolin inducedL99762-7Clot angle in Blood by Thromboelastography.resonance.kaolin inducedL99763-5Clot formation [Time] in Blood by Thromboelastography.resonance.kaolin inducedL